Jay Achar

Eng koʻp iqtibos qilingan asarlar

1. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20163 iqtibos
2. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan20203 iqtibos
3. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan20181 iqtibos
4. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis20191 iqtibos
5. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis20181 iqtibos
6. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan20201 iqtibos
7. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan20201 iqtibos
8. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen20150 iqtibos
9. Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan20210 iqtibos
10. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study20240 iqtibos

Hammualliflar

1. Nargiza Parpieva10 ta umumiy asar2015–2024
2. Philipp du Cros5 ta umumiy asarSkelet yozuvlar: 12014–2020
3. Zinaida Tigay5 ta umumiy asar2015–2020
4. Giovanni Battista Migliori3 ta umumiy asar2019–2024
5. Khasan Safaev3 ta umumiy asar2020–2024
6. Atadjan Khamraev3 ta umumiy asar2015–2020
7. Dennis Falzon3 ta umumiy asar2016–2019
8. Jane Greig2 ta umumiy asarSkelet yozuvlar: 12014–2020
9. Catherine Berry2 ta umumiy asarSkelet yozuvlar: 12014–2020
10. Gunta Dravniece2 ta umumiy asar2019–2024

Barcha hammualliflar →